Freeze drying of in vitro diagnostics
Biopharma Group is hosting the 3rd edition of the popular freeze drying seminar series at the University of Cambridge. This year, the focus is on "Freeze Drying of In Vitro Diagnostics".
30 April 2024Biopharma Group is hosting the 3rd edition of the popular freeze drying seminar series at the University of Cambridge. This year, the focus is on "Freeze Drying of In Vitro Diagnostics".
30 April 2024A variety of factors like powder flow, material characteristics, compression pressure, turret speed, etc can affect tablet quality and production run time. Any resulting tablet defects can exacerbate production costs or even result in no product at all! Therefore, it’s necessary to characterise the tablet compression process to achieve robust tablets.
2 April 2024Following the postponement of an in-person EMC2020 due to the pandemic, we’re delighted that EMC2024 is taking place from Sunday 25th August to Friday 30th August 2024 in Copenhagen. EMC2024 is the 17th of its kind and will bring the world of scientific imaging together in one of Europe’s most beautiful cities - Copenhagen, Denmark.
24 January 2024IPT caught up with Peter O’Toole, president of the Royal Microscopical Society, to hear how his first few months as president have gone, his plans for the Society and how the field of microscopy might develop over the next few years
20 December 2023Natoli engineering has made significant contributions to the pharmaceutical and nutraceutical industries. Specialising in tablet compression and encapsulation technology, innovative machines, tooling and solutions that enhance tablet and encapsulation manufacturing processes, Natoli has advanced manufacturing technologies and practices worldwide
24 September 2023'Increasing economic challenges like market vitality, product diversification and cost pressure lead to the need for faster process design' − and that is not to mention the shorter innovation cycles and increasing demand for small batch production. The module type package suite from COPA-DATA meets these needs
24 September 2023LASER COMPONENTS manufacturers single photon counting modules which offer a unique combination of high quantum efficiency, wide dynamic range and ease of use.
Product Profile, 23 July 2024LASER COMPONENTS is pleased to introduce the iC-LA and iC-LF series CMOS linear image sensors from iC-Haus. The integrating light-to-voltage converters are available with up to 1024 active photo pixels in a linear array. The integrated control logic makes operation very simple, with only a start and clock signal necessary. A third control input (DIS) acts as an electronic shutter.
Product Profile, 15 July 2024Measuring the radiation of sunlight is critical to several applications, from solar power to scientific research.
Product Profile, 1 July 2024Meet Celledonia, the new and revolutionary benchtop cell analyser that will inform and expedite your bioprocesses and turn your data into actionable insights.
Product Profile, 12 June 2024LASER COMPONENTS offers ruled and holographic diffraction gratings, covering the UV, visible and near infra-red range from partners Optometrics.
Product Profile, 11 June 2024• New facilities adjacent to the Cambridge Science Park will comprise CL2 wet labs, dry labs and office space over six storeys • Latest ground-up development in Cambridge delivered by Kadans Science Partner to provide the facilities needed by health, life science and technology companies
Press Releases, 23 July 2024• Trial aims to deliver clinical proof-of-concept and assess the safety profile of novel long acting ENaC inhibitor ETD001 • ETD001, a CFTR mutation agnostic approach to CF, is focussed on providing a novel treatment for members of the CF community that do not benefit from currently available mutation-targeted therapies
Press Releases, 23 July 2024We are proud media partners of Elrig's Drug Discovery 2024!
Press Releases, 18 July 2024Gaelic Laboratories unveils its new website today, launching an upgraded and expanded laboratory technology base for advanced analytical testing, and a newly re-fitted Beta-Lactam manufacturing facility, using the latest state-of-the art technology.
Press Releases, 10 July 2024Come and join us for the 13th edition of BioFIT, on December 3rd & 4th, 2024 in Lille and digital meetings days on December 11th & 12th, 2024!
Press Releases, 9 July 2024Frailty should not be considered an inevitability, but the effects can be significant. How can technological innovations combat this?
Digital, 7 July 2024While still in its infancy, it is estimated that both AR and VR will surpass 100 million users worldwide by 2027. In realising this trend, it is clear that organisations adopting AR/VR app development services to create immersive experiences for their users which may enable them to excel within the realm of healthcare
Digital, 20 December 2023Ensuring a robust foundation of performance metrics to underpin a strategy is key to navigating the challenges and getting fit for growth. However, amid firefighting to overcome day-to-day challenges, knowing where to start in setting key performance indicators and finding the right ways to track, measure and analyse them to glean actionable insights can often be a minefield that is easily sidelined
Digital, 20 December 2023In the UK, one in 50 adults is living with a chronic wound, leading to more than £8bn in healthcare costs in 2017/2018. However, these numbers are likely to be higher since the pandemic as a result of reduced care in 2020 and 2021, impacting patient outcomes. With a growing ageing population and the increasing prevalence of people with comorbidities, these costs are likely to continue to rise until new solutions can be implemented to improve current standard care and control
Digital, 20 December 2023An exploration of the thoughts on the significance of generative AI within life sciences and pharma
Digital, 24 September 2023Protein-based immunotherapies, such as monoclonal antibodies and adoptive cell transfer therapies, are reshaping oncology treatments, but ensuring their safety and efficacy is crucial for their success
Medical devices should be designed with an awareness of the challenges of a specific disease as well as an awareness of equality, and the uk government has recently produced a new initiative around this, but how will this impact medical device production going forward?
Protein synthesis is the process by which cells build proteins, fundamental molecules necessary for virtually all cellular functions, but how can this be used within the discovery and manufacturing of new drugs and how can it be automated?
This article explores the significant opportunities within the biologics contract development and manufacturing organisation (CDMO) industry to optimize client satisfaction by meeting the critical demands of discerning clients. Six key facets are identified as pivotal to success, while underscoring the fundamental role of a client-centric approach and the importance of building and nurturing strong client relationships.
Robots are revolutionising manufacturing, but manual programming hampers their potential. Robot offline programming offers a digital solution, reducing human work hours by up to 80% and ensuring swift task readiness
In the post-covid-19 era, healthcare grapples with staff shortages and treatment delays, emphasising the need for early diagnosis. While regulatory changes pose challenges, eu extensions provide relief
Proteins govern crucial biological processes, making protein-protein interactions vital for understanding and treating diseases, peptide-based mimics offer tailored therapeutic approaches, yet optimising their efficacy poses challenges
After assessing the various routes of drug administration, oral delivery stands out as the safest and, as a result, the most universally accepted among patients. Single-unit dosage forms, including tablets followed by capsules, have been identified as the preferred designs for immediate or modified release formulations
Drug administration by inhalation is an established technique for treating respiratory and systemic diseases. Effective drug delivery to the lungs requires the aerosolisation and dispersion of a formulation into particles or droplets in the inhalable size range, typically an aerodynamic diameter below 5 µm. In many cases, particle engineering is used to optimise a formulation for efficacy
Refeyn discusses the challenges associated with AAV manufacture, the key analytical techniques currently used to facilitate insight into AAV samples and novel techniques striving to overcome current limitations
By seamlessly integrating a dynamic MES into digitisation road maps, companies have achieved greater operational efficiency, data integrity and harnessed real-time insights to meet their strategic goals
Natoli engineering has made significant contributions to the pharmaceutical and nutraceutical industries. Specialising in tablet compression and encapsulation technology, innovative machines, tooling and solutions that enhance tablet and encapsulation manufacturing processes, Natoli has advanced manufacturing technologies and practices worldwide
While the drug-device combination product industry is always investing in technology that could better meet the needs of patients, governments and sponsors, the COVID-19 pandemic has accelerated the process, bringing in more outside investment and a broader range of organisations in active development
What are some trends in the mRNA space surrounding the growing desire for speed-to-market, and what hurdles are impeding the achievement of this goal?
Drug product optimisation, also known as reformulation, is a development step required by all drugs en route to market. This process takes a long time, carries a considerable cost and places significant emphasis on the predictive power of laboratory and preclinical assessments. What are some alternative pathways available to development teams?
For different binder-diluent ratios on the tablet mechanical strength, a proposed scale could serve as a ‘guiding torch’ for various formulators while designing preclinical or early phase formulations
With the lab of the future becoming increasingly automated, how will this change workflows and how can the industry prepare for this?
The pharmaceutical sector is characterised by intricate processes, stringent regulations and a constant demand for innovation. However, the industry's digital transformation is hindered by the prevalence of legacy machinery, which often poses compatibility challenges when deploying new technology. COPA-DATA explains the method of standardisation to remove the barriers of integration of legacy equipment in labs and production lines
'Increasing economic challenges like market vitality, product diversification and cost pressure lead to the need for faster process design' − and that is not to mention the shorter innovation cycles and increasing demand for small batch production. The module type package suite from COPA-DATA meets these needs
Lab layouts, until the introduction of automation, had seen little change in decades. However, the increased usage of hardware and software lab automation has reduced repetitive manual tasks and drastically increased the walkaway time involved in experiments
Whether lab managers are enthusiastic or apprehensive, AI is coming to the lab. The key to building this advantage is not in the technology, but the approach. Successful adoption of AI requires a genuine, long-term commitment. IPT spoke to Bob Voelkner at LabVantage Solutions about the implications of AI for pharma, what it takes to succeed with this new technology and his five recommended steps for getting started
LabVantage Solutions’ Pharmaceutical LIMS is Engine for Digital Transformations
Healthcare and scientific facilities are critical for the health of the global population. During the COVID-19 pandemic, scientific facilities helped to deliver life-saving vaccines, re-emphasising their importance in achieving other scientific milestones in the coming decades
The digitalisation of pharmaceutical manufacturing has come a long way. However, there are still many ways companies can improve systems to grow even further
Pharmaceutical companies face plenty of challenges throughout the manufacturing cycle. Automation can be the key to bringing the industry to the forefront of this exciting field
IPT speaks to Toon Overbeeke of Vitestro about the potential benefits of using robots in clinics to draw blood from patients. With a shortage of clinical staff all over Europe, Toon believes robotics is the way forward regarding individual clinical patient care
IPT speaks to Mikael Hagstroem, CEO of LabVantage Solutions, about the ongoing potential for laboratories of adopting AI and machine learning (ML)
Smart automation is enabling new ways to monitor and intervene pre-emptively in pharma manufacturing. Find out the views of industry experts, who debated the subject in a roundtable video discussion.
The repercussions of events like Brexit and the global pandemic have caused uncertainty and a need to rethink strategy altogether. However, an integrated SaaS solution can provide a holistic view of the business and enhanced control over processes.
Since the completion of the human genome project in 2003, there has been huge growth in the utilisation of genomics, but how can partnerships in this area be used to improve patient experience
Discovery and Development, 7 July 2024Synthetic biology has been a cornerstone in recent health advancements, including drug discovery, development and manufacturing, however there are challenges facing this market
Discovery and Development, 7 July 2024The development and use of novel gene therapy approaches is increasing. With the advent of innovative technologies using improved tropism and safer viral-based systems, and nanotechnology advancing non-viral delivery of nucleic acid vectors, there will be more gene-based products entering the market in near future
Discovery and Development, 18 March 2024Ipt talks with jacob tesdorpf at revvity about the recent developments in preclinical imaging, from ai-enchanced analysis to refined disease models
Discovery and Development, 18 March 2024The World Health Organization (WHO) has recognised the scarcity of new antimicrobial agents in the clinical pipeline. The prevailing approach to combatting antimicrobial resistance cannot solely rely on developing new drugs. Instead, we must seek ways to better understand and more efficiently use the drugs already at our disposal.
Discovery and Development, 20 December 2023Thermo fisher scientific discusses the role of process analytical technology in addressing the process challenges concerning fermentation and cell culture in biotechnology and enhancing quality and speed production
Analytics, 18 March 2024Recent advancements in MALDI mass spectrometry imaging are transforming disease understanding and treatment. This innovation promises rapid diagnostics and personalised medicine, with reliable imaging within five years
Analytics, 18 March 2024IPT caught up with Peter O’Toole, president of the Royal Microscopical Society, to hear how his first few months as president have gone, his plans for the Society and how the field of microscopy might develop over the next few years
Analytics, 20 December 2023IPT talks to Yama Abassi at Agilent about immunology and cell analysis and how these will develop in the future
Analytics, 20 December 2023Droplet-based single-cell analysis systems provide an invaluable tool to accelerate research and development. Recent scientific advances enhance the applicability of these droplet-based systems to address the age-old problem of characterising, understanding and selecting cells
Analytics, 24 September 2023Www.mmc-series.org.uk
Analytics, 24 September 2023We are proud media partners of Elrig's Drug Discovery 2024!
Conferences and Events , 18 July 2024Come and join us for the 13th edition of BioFIT, on December 3rd & 4th, 2024 in Lille and digital meetings days on December 11th & 12th, 2024!
Conferences and Events , 9 July 2024LSX Nordic Congress gathers the founders and CEOs of innovative start-ups through to publicly listed healthcare giants, and everyone in between. It represents the breadth and depth of cutting-edge research and technology driving the advances in the industry right now and in the near future.
Conferences and Events , 8 July 2024ACHEMA 2024 took place 10-14 June 2024 in Frankfurt, Germany, with 2,842 exhibitors from 56 nations covering the latest equipment and innovative processes for the chemical, pharmaceutical and food processing industries
Conferences and Events , 16 June 2024Just over a month before ACHEMA 2024 opens on 10 June, one thing is already clear: with more than 60 percent of exhibitors coming from abroad, this year's leading trade show for the global process industry will be the most international ACHEMA ever. Numerous side events from renowned partners await participants from 130 countries.
Conferences and Events , 13 May 2024Join the world's leading orphan drug and rare disease Congress! 📅 22-25 October, 2024 📍Fira De Barcelona, Montjuic, Barcelona, Spain
IPT TV, 22 July 2024Take a look at our trailer for the world's leading vaccine event! The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meetings of their kind across the globe since 2000.
IPT TV, 22 July 2024Just over a month before ACHEMA 2024 opens on 10 June, one thing is already clear: with more than 60% of exhibitors coming from abroad, this year's leading trade show for the global process industry will be the most international ACHEMA ever. Numerous side events from renowned partners await participants from 130 countries.
IPT TV, 16 May 2024Next Ilmac in Lausanne: 18 and 19 September 2024 | Beaulieu Lausanne Next Ilmac in Basel: 16 - 18 September 2025 | Messe Basel, Hall 1.0 All information at: www.ilmac.ch
IPT TV, 16 April 2024INTERPHEX, the premier pharmaceutical and biotechnology event taking place April 16-18, 2024, at the Javits Center in NYC, is proud to introduce INTERPHEX Conference, an all-new, transformative event that will enrich the meeting experience for attendees, starting in 2024.
IPT TV, 9 April 2024